| New Drug to Treat Sexual Dysfunction An experimental spray improved sexual experiences for some men who experience premature ejaculation, according to two studies to be released Tuesday. online.wsj.com |
Court Rejects Appeal on Hormone Therapy The Supreme Court rejected a bid by Pfizer's Wyeth unit to obtain a full new trial on an Arkansas woman's claims that taking a combination of hormone-therapy drugs caused her to develop breast cancer. online.wsj.com |
Medtronic to Buy Osteotech for $123 Million Medtronic said it will buy Osteotech for about $123 million. Osteotech, a provider of human bone and bone connective tissue used in transplants, has been embroiled in a proxy battle. online.wsj.com |
BMS Acquisition of ZymoGenetics Highlights Competitive Hepatitis C Treatment Race Douglas Cress submits:By vandersonBristol-Myers Squibb (BMY) announced Tuesday that it had signed an agreement to acquire biopharmaceutical company ZymoGenetics (ZGEN) for $9.75 per share in cash, or approximately $885 million. Under the terms of the agreement, BMS will gain control of ZymoGenetics’ product development pipeline, which includes potential treatments for surgical bleeding, metastatic skin cancer, and atopic dermatitis.Complete Story » seekingalpha.com |
Cardinal Health Buys Chinese Firm Cardinal Health is buying privately held Zuellig Pharma China, that country's largest pharmaceutical importer, for $470 million including assumption of debt. online.wsj.com |